ALPINE IMMUNE SCIENCES INC stock forecast: up to 11.37 USD ALPN stock price prognosis


Forecast for Fri 17 Nov 2023 price 10.54

ALPINE IMMUNE SCIENCES INC stock price forecast for further price development up to 46.13% (time horizon: 1 day) and price target of 11.37 USD. Short-term (time horizon: 2 weeks) ALPINE IMMUNE SCIENCES INC share price prediction for 2023-11-17 with daily closed price projections

Key Facts

Symbol ALPN 

ISIN US02083G1004 

CUSIP 02083G100

Currency USD

Category Pharmaceutical Preparations

Forecast price change %

Finance numbers

Revenue 11,448,000.0

Earnings per share -1.49

On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.

Summerized Form 10-K with GPT-2

In addition, we are eligible to receive tiered royalties on net sales of ALPN-101. ICOS is, however, rapidly induced upon T cell activation. We plan to determine expansion cohorts later this year. More information is available at (NCT04186637). Examples of additional multi-target compounds for immuno-oncology are highlighted below. Each of these patent applications is solely owned by us. As a result, its ultimate impact, implementation, and meaning are subject to uncertainty. A company can make only those claims relating to safety and efficacy approved by the FDA. Such off-label uses are common across medical specialties. These laws may impact, among other things, our proposed sales and marketing strategies. Moreover, clinical data are often susceptible to varying interpretations and analyses. In most countries, the pricing of prescription drugs is subject to governmental control. We have had significant operating losses since inception. Our business may be affected by litigation and government investigations. However, we may never receive such designation. Therefore, these provisions could adversely affect the price of our stock. Item 1B. Unresolved Staff Comments.

Summerized Form 10-K with GPT-2
Candlestick patterns

Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.

  • Meta analyst score 26.04/100
    • Good financial position.
    • Historical view, profit is not growing.
    • Company revenue is not growing faster compared with the industry.

Institutional ownership list is based on filling form information

Holding name Date Amount
A - BARCLAYS PLC 2023-06-30 6325
China Universal Asset Management Co., Ltd. 2023-06-30 629
MetLife Investment Management, LLC 2022-12-31 12028
JPMORGAN CHASE & CO 2023-03-31 48149

Fund ownership list is based on filling form information

Fund name Date Amount Profile
Fidelity Concord Street Trust 2023-02-28 21624 Long
Fidelity Concord Street Trust 2023-02-28 140494 Long
TIAA-CREF Funds 2023-01-31 31004 Long

Bollinger Bollinger Bands for ALPINE IMMUNE SCIENCES INC can provide the information where the market is moving based on price information.

ALPINE IMMUNE SCIENCES INC Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.

Converting prices to returns ALPINE IMMUNE SCIENCES INC.

On-Balance Volume information for ALPINE IMMUNE SCIENCES INC. On-Balance Volume information can be an indicator for bullish or bearish outcome.

Accumulation / Distribution (A/D) indicator information for ALPINE IMMUNE SCIENCES INC. The indicator identify divergences between price and volume flow.

Aroon Oscillator information for ALPINE IMMUNE SCIENCES INC. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.

Average Directional Index (ADX) information for ALPINE IMMUNE SCIENCES INC. The index can be used to identify the strengh of a trend.

Moving Average Convergence Divergence (MACD) for ALPINE IMMUNE SCIENCES INC. The indicator helps to predict trend direction and the momentum of the trend.

Stochastic Oscillator as momentum indicator for ALPINE IMMUNE SCIENCES INC. The indicator is useful for identifying overbought and oversold levels.

Relative Strength Index (RSI) for ALPINE IMMUNE SCIENCES INC. RSI is a momentum oscillator that measures the speed and change of price development. The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period. Primary usage of the indicator is to identify overbought or oversold signals. When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30 [ Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio ].

Heikin Ashi trading signals are generated based on the Heikin Ashi candles, which are a type of candlestick that smooths out the price action and can help to identify trends. Heikin Ashi signals can be used to identify both long and short trading opportunities.

The awesome oscillator is a momentum indicator that measures the speed and strength of price movements. It is calculated by subtracting a 34-period simple moving average (SMA) from a 5-period SMA.

The Parabolic SAR indicator is a trend-following indicator that uses a series of dots to indicate when a trend is likely to reverse. The Parabolic SAR is a lagging indicator, meaning that it does not predict reversals, but rather confirms them after they have already occurred.

52W High 52W Low Market Cap

Similar shares



Figure below show the stock predictions.
Date Closing price Prediction was updated
2023-09-27 11.37 2023-09-23 14:05
2023-09-28 11.44 2023-09-23 14:05
2023-10-06 11.21 2023-09-23 14:05
2023-10-19 10.95 2023-09-23 14:05
2023-09-25 11.44 2023-09-23 14:05
2023-10-13 11.03 2023-09-23 14:05
2023-09-26 11.31 2023-09-23 14:05
2023-09-29 11.41 2023-09-23 14:05
2023-10-04 11.26 2023-09-23 14:05
2023-10-20 10.91 2023-09-23 14:05
2023-10-05 11.28 2023-09-23 14:05
2023-11-13 10.61 2023-09-23 14:05
2023-10-02 11.33 2023-09-23 14:05
2023-10-03 11.21 2023-09-23 14:05
2023-11-02 10.73 2023-09-23 14:05
2023-11-08 10.66 2023-09-23 14:05
2023-10-17 11.00 2023-09-23 14:05
2023-10-18 10.97 2023-09-23 14:05
2023-10-09 11.13 2023-09-23 14:05
2023-11-10 10.63 2023-09-23 14:05
2023-11-03 10.71 2023-09-23 14:05
2023-10-10 11.11 2023-09-23 14:05
2023-10-27 10.80 2023-09-23 14:05
2023-10-11 11.14 2023-09-23 14:05
2023-10-12 11.11 2023-09-23 14:05
2023-11-15 10.57 2023-09-23 14:05
2023-10-23 10.90 2023-09-23 14:05
2023-10-24 10.88 2023-09-23 14:05
2023-10-16 11.00 2023-09-23 14:05
2023-10-25 10.87 2023-09-23 14:05
2023-11-09 10.64 2023-09-23 14:05
2023-11-06 10.70 2023-09-23 14:05
2023-11-07 10.68 2023-09-23 14:05
2023-10-26 10.83 2023-09-23 14:05
2023-10-30 10.80 2023-09-23 14:05
2023-10-31 10.78 2023-09-23 14:05
2023-11-01 10.76 2023-09-23 14:05
2023-11-16 10.56 2023-09-23 14:05
2023-11-14 10.59 2023-09-23 14:05
2023-11-17 10.54 2023-09-23 14:05

The forecast (dashed curve) of the share price performance is based on historical data. Our forecast model is based on mathematical, statistical methods. The website offers price forecasts and analysis tools for equities and other securities, which are exclusively based on the prices of these securities in the past. Information about these prices is provided to us by third parties. Although we believe, If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and correct sequencing of this information. We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider any financial data or other data of such issuers with the exception of the past prices of the securities. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or circumstances, that may be relevant for future security price flows. Investments require additional considerations. Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor or the tax implications an investment may have for the investor. Although we believe that our mathematical models are a tool to try to explore the possibility for future price development with the help of past performance, such developments are subject to a multitude of different influences. and therefore not really predictable. We cannot guarantee the success of any investment you make based on the information published here. This website is for information purposes only. All information and data on this website cannot be guaranteed to be accurate, accuracy, completeness and appropriateness - neither explicit nor implicit.